FEVIX
Price
$26.80
Change
+$0.25 (+0.94%)
Updated
Sep 3 closing price
Net Assets
1.7B
RIDCX
Price
$28.24
Change
-$0.13 (-0.46%)
Updated
Sep 4 closing price
Net Assets
148.23B
Interact to see
Advertisement

FEVIX vs RIDCX

FEVIX vs RIDCX Comparison Chart in %
View a ticker or compare two or three
VS
FEVIX vs. RIDCX commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEVIX is a Buy and RIDCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIDCX has more cash in the bank: 148B vs. FEVIX (1.7B). RIDCX pays higher dividends than FEVIX: RIDCX (3.08) vs FEVIX (1.88). FEVIX was incepted earlier than RIDCX: FEVIX (25 years) vs RIDCX (24 years). RIDCX (0.90) and FEVIX (0.89) have similar cost to investors . RIDCX is a more actively managed with annual turnover of: 65.00 vs. FEVIX (16.89). RIDCX has a lower initial minimum investment than FEVIX: RIDCX (250) vs FEVIX (1000000). FEVIX annual gain was more profitable for investors over the last year : 13.40 vs. RIDCX (7.86). FEVIX return over 5 years is better than : 27.60 vs. RIDCX (23.21).
FEVIXRIDCXFEVIX / RIDCX
Total Expense Ratio0.890.9099%
Annual Report Gross Expense Ratio0.890.9099%
Fund Existence25 years24 years-
Gain YTD12.5589.924127%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.7B148B1%
Annual Yield % from dividends1.883.0861%
Returns for 1 year13.407.86170%
Returns for 3 years40.3139.29103%
Returns for 5 years27.6023.21119%
Returns for 10 years40.7055.2974%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFEKX209.28N/A
N/A
MFS Growth R6
VALLX49.02-0.09
-0.18%
Value Line Larger Companies Focused Inv
CDEYX22.11-0.04
-0.18%
Columbia Intrinsic Value Institutional 3
DSFRX41.98-0.14
-0.33%
Domini Impact Equity Y
APFDX20.71-0.07
-0.34%
Artisan Global Discovery Investor